Monoclonal Antibodies: The Foundation of Therapy for Colorectal Cancer in the 21st Century?
2004
Drs. Hoff, Ellis, and Abbruzzese have provided a thorough and useful overview of the current status of the two new monoclonal antibodies, cetuximab (Erbitux) and bevacizumab (Avastin), that have recently become available for the treatment of colorectal cancer.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI